Network Meta-Analyses: Much more than a press-the-button exercise

Some of the input data is missing for some studies. How do you deal with these missings - just exclude them?

You compare many treatments with each other in a pairwise way. How do you best communicate this large matrix of pairwise comparisons?

You need to adapt your NMA last minute because there was a delay in the system and your systematic literature search became outdated. Do you need to postpone the launch of the new product by a couple of weeks?

You got regulatory approval for a new indication earlier than expected. While the regulatory team celebrates the achievement you worry that you need to have your NMA ready 3 months earlier. Will you be able to deliver?

We discuss these and many more problems of NMAs.

If you would like to get help around these, write an email to [email protected] or contact me via LinkedIn.